Hybrid Conferencee

International Conference on Pharmacology and Therapeutics in Diabetes (ICPTD - 26)

25th - 26th September 2026 | Munich, Germany

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Munich. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Munich event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Munich conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Munich, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Munich."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Innovations in Drug Development for Diabetes

This track focuses on the latest advancements in pharmacological research aimed at developing novel therapeutic agents for diabetes management. Participants will explore cutting-edge methodologies and technologies that enhance drug efficacy and safety profiles.

Track 02

Mechanisms of Action in Diabetes Pharmacotherapy

This session delves into the biochemical and physiological mechanisms underlying the action of diabetes medications. Understanding these mechanisms is crucial for optimizing therapeutic strategies and improving patient outcomes.

Track 03

Clinical Applications of Diabetes Therapeutics

This track examines the real-world application of pharmacological treatments in diverse patient populations with diabetes. Discussions will include case studies and clinical trials that highlight the effectiveness of various therapeutic approaches.

Track 04

Pharmacokinetics in Diabetes Treatment

This session addresses the pharmacokinetic principles that influence the absorption, distribution, metabolism, and excretion of diabetes medications. A thorough understanding of these principles is essential for optimizing dosing regimens and enhancing therapeutic efficacy.

Track 05

Patient Adherence to Diabetes Therapies

This track investigates the factors influencing patient adherence to prescribed diabetes treatments. Strategies to improve compliance and the impact of adherence on treatment outcomes will be discussed.

Track 06

Safety and Efficacy of Diabetes Medications

This session focuses on the evaluation of safety and efficacy profiles of existing and emerging diabetes therapies. Participants will review clinical trial data and post-marketing surveillance studies to assess risk-benefit ratios.

Track 07

Emerging Therapies in Diabetes Management

This track highlights novel therapeutic agents and innovative treatment modalities currently under investigation for diabetes management. The discussion will encompass the potential impact of these emerging therapies on clinical practice.

Track 08

Optimization of Diabetes Treatment Regimens

This session explores strategies for optimizing treatment regimens for individuals with diabetes, including personalized medicine approaches. Emphasis will be placed on tailoring therapies to meet the unique needs of diverse patient populations.

Track 09

Role of Technology in Diabetes Therapeutics

This track examines the integration of technology, such as digital health tools and telemedicine, in enhancing diabetes management. The potential of these innovations to improve patient engagement and treatment outcomes will be discussed.

Track 10

Pharmacogenomics in Diabetes Therapy

This session focuses on the role of pharmacogenomics in personalizing diabetes treatment. Participants will explore how genetic variations influence drug response and the implications for individualized therapy.

Track 11

Global Perspectives on Diabetes Pharmacotherapy

This track provides a platform for discussing global trends and challenges in diabetes pharmacotherapy. Participants will share insights on healthcare disparities, access to medications, and culturally appropriate treatment strategies.